Quick answer: As of October 2026, the checkpoint inhibitors available to patients in India include pembrolizumab (Keytruda), nivolumab (the originator plus the biosimilars Tishtha and Nivorz), atezolizumab (Tecentriq), durvalumab (Imfinzi),...
Read More
Patients with advanced or difficult-to-treat cancers now have hope thanks to immune checkpoint inhibitors, a breakthrough in cancer treatment. Unlike...
Read More
For many years, doctors have been battling cancer. They've used surgery, chemotherapy, and radiation therapy effectively, but these treatments aren't...
Read More
For more than a century, doctors have been interested in using viruses to treat cancer, and in recent years a...
Read More
The immune system uses special proteins called antibodies to fight off germs and other invaders. These antibodies stick to specific...
Read More
Most symptoms associated with chronic illnesses stem from the immune response and subsequent inflammation. This immune response can directly damage...
Read More
In the quest to combat diseases such as cancer, medical science has made great advancements in the last two decades...
Read More
For over a century, medical practitioners have explored the potential of using viruses to combat cancer. In recent years, a...
Read More
Cancer treatment in India has come a long way, expanding beyond surgery, chemotherapy, and radiation. Today, targeted therapies and advanced...
Read More
Emerging as the 4th modality of cancer immunotherapy has shown considerable promise when it comes to treating a wide range...
Read More
